Welcome to our dedicated page for Gold River Prod SEC filings (Ticker: GRPS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Trans American Aquaculture, Inc. filings document the company's public reporting, capital structure, financing agreements, and compliance status as a Colorado emerging growth company associated with the GRPS ticker. Recent 8-K filings report material definitive agreements involving Series D Preferred Stock financing, while Exchange Act notices address annual and quarterly reporting timelines.
The filing record includes Form 12b-25 notifications related to delayed 10-K and 10-Q reports and auditor review completion, along with disclosures on securities registration status, issuer classification, and corporate governance context. These documents provide formal records for the aquaculture operator's reporting obligations, preferred equity transactions, and public-company controls.
Trans American Aquaculture, Inc. submitted a Form 12b-25 notifying the SEC of a late Form 10-Q for the period ended March 31, 2026. The company states it "has been unable to complete the review process with the auditor." The notice is signed by Adam Thomas, Chief Executive Officer, dated May 15, 2026. The filing also indicates the Annual Report on Form 10-K for the year ended December 31, 2025 has not been filed.
Trans American Aquaculture, Inc. entered a Securities Purchase Agreement with GHS Investments LLC for 59 shares of Series D Preferred Stock at $1,000 per share, for $59,000 at the initial closing on March 26, 2026.
Each share has a stated value of $1,200 and accrues 8% annual dividends, payable in cash or additional preferred shares. GHS also received six commitment shares and a warrant to purchase up to 243,750,000 common shares at $0.000161 per share, expiring March 26, 2031, with full-ratchet anti-dilution and a 4.99% beneficial ownership limit, adjustable up to 9.99%. The company may sell up to 13 additional Series D shares. The securities were sold privately under Section 4(a)(2) and Rule 506 of Regulation D with no sales commissions.
Trans American Aquaculture, Inc. submitted a Form 12b-25 notification that its annual report on Form 10-K for the period ended December 31, 2025 will be filed late because the company "has been unable to complete the review process with the auditor."
Trans American Aquaculture, Inc. reported continued operating losses and no shrimp revenue in its quarter ended September 30, 2025. For the three months, revenue was $0 and the net loss was $171,642, improving from a loss of $575,325 a year earlier mainly due to lower cost of goods sold and reduced legal, professional, and payroll expenses. For the nine months, revenue was also $0 versus $315,145 in 2024, with the net loss narrowing to $489,387 from $1,143,656.
The balance sheet shows a strained financial position, with current liabilities of $4,719,609 and current assets of $340,123, creating a working capital deficit of $4,379,486 and a stockholders’ deficit of $3,758,603. Cash was just $509 at quarter-end, and shareholders have loaned about $1,646,636 at double‑digit interest rates. The company exited Chapter 11 bankruptcy in October 2025 but still faces going concern uncertainty and is relying on GHS Investments equity financing and preferred stock and warrant issuances to fund operations. Common shares outstanding were 1,805,926,955 as of January 14, 2026.
Trans American Aquaculture, Inc. (GRPS) filed a Form 12b-25, notifying a late filing of its Form 10-Q for the period ended September 30, 2025. The company cites that it has been unable to complete the review process with its auditor.
Form 12b-25 is a standard notice used when a registrant cannot meet a filing deadline. The narrative identifies the audit review as the cause of delay, without additional financial details.
Trans American Aquaculture, Inc. filed Amendment No. 1 to its Q2 2025 Form 10‑Q to revise the Balance Sheet and Statements of Stockholders’ Equity, reconciling the common stock issued value to the appropriate prior quarter and making a minor reclassification to a preferred stock to be issued line; it also furnishes XBRL Exhibit 101. No other changes to the original report.
Operations remain limited: Q2 2025 revenue was $0 (vs. $5,019 in Q2 2024) and net loss was $204,038. For the six months ended June 30, 2025, revenue was $0 (vs. $315,145 in 2024) and net loss was $317,745 (vs. $568,332). Cash was $198 at June 30, 2025, with current assets of $303,323 and current liabilities of $4,654,029, a working capital deficit of $4,350,706. Shares outstanding were 1,805,926,955 as of October 9, 2025.
The company discloses a going concern uncertainty and a voluntary Chapter 11 filing in December 2024, with a plan confirmation hearing scheduled for August 18, 2025. Management also reports a material weakness in internal control over financial reporting.
Trans American Aquaculture (GRPS) filed its quarterly report, highlighting continued operating losses and liquidity stress. The company reported $0 revenue for both the three and six months ended June 30, 2025, with net losses of $204,038 and $317,745, respectively. Cash was $198 at quarter‑end, and current liabilities exceeded current assets by $4,350,706, indicating a significant working capital deficit.
The company remains under Chapter 11 protection following a December 2024 filing, with a plan confirmation hearing scheduled for August 18, 2025. Operations are paused; the company is maintaining broodstock only. Inventory totaled $302,409, primarily broodstock. Interest expense fell year over year, aiding a narrower loss.
To access funding, the company continued using preferred stock and warrant issuances with GHS, and it also disclosed an equity financing agreement that permits periodic common stock “puts.” Shares outstanding were 1,805,926,955 as of October 9, 2025. Management disclosed a going concern uncertainty and material weakness in internal control over financial reporting.
Trans American Aquaculture, Inc. entered into a financing agreement with GHS Investments LLC that allows the company to sell up to 63 shares of Series D Preferred Stock for up to $60,000. At the initial closing on September 18, 2025, GHS purchased 19 shares of Series D Preferred Stock, including three shares for legal fees, and received an additional six commitment shares.
At each closing, GHS also receives warrants equal to 50% of the common shares issuable upon conversion of the purchased Series D Preferred Stock. At the initial closing, the company issued warrants to purchase up to 71,250,000 common shares at $0.000345 per share, exercisable until September 18, 2030. Separately, the company approved a 12‑month consulting agreement with Redhawk Investment Group that includes a $140,000 retainer and additional fees totaling $360,000, payable in cash or preferred stock.
Trans American Aquaculture, Inc. entered into a financing agreement with GHS Investments LLC that allows the company to sell up to 63 shares of Series D Preferred Stock for up to $60,000. At the initial closing on September 18, 2025, GHS purchased 19 shares of Series D Preferred Stock, including three shares for legal fees, and received an additional six commitment shares.
At each closing, GHS also receives warrants equal to 50% of the common shares issuable upon conversion of the purchased Series D Preferred Stock. At the initial closing, the company issued warrants to purchase up to 71,250,000 common shares at $0.000345 per share, exercisable until September 18, 2030. Separately, the company approved a 12‑month consulting agreement with Redhawk Investment Group that includes a $140,000 retainer and additional fees totaling $360,000, payable in cash or preferred stock.